However, the frequent and painful IM injections present a great burden for patients and their families, and subcutaneous (SQ) OHCbl administration has been suggested as an alternative parenteral route [9]
The expression of c-Met RTK protein was studied in seven melanoma cell lines and the 140-kDa subunit of c-Met protein was expressed in six of seven melanoma cell lines
Gastrointestinal side effects are the primary clinical concern: nausea (44%), diarrhea (30%), vomiting (24%), and constipation (24%) are common, particularly during dose escalation
Together, these peptides address fibrosis, inflammation, and cellular repairkey factors in renal pathology
With proper care, most patients return to full activity without long-term issues